Brown K O, Goldschmiedt M
Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas.
Endoscopy. 1994 Nov;26(9):719-23. doi: 10.1055/s-2007-1009082.
Although many reports in the literature describe the use of endoscopic retrograde cholangiopancreatography (ERCP) in children, few mention the therapeutic application of the technique in treating pediatric patients with pancreatic or biliary pathology. We report here on our two-year experience, consisting of 42 ERCPs conducted in 25 patients for a variety of pancreaticobiliary indications. Ages ranged from 22 months to 19 years. Five patients had normal studies; the remainder were diagnosed with a variety of pancreatic and or biliary anomalies. Seventeen patients had therapeutic interventions consisting of sphincterotomy (n = 12), dilation (n = 6), or stent placement (n = 9), with many of these procedures being done in combination. Five patients had mild complaints of abdominal pain or vomiting immediately after ERCP, but no major technical or medical complications were encountered. We find that therapeutic ERCP can be safely performed in children, but only by highly experienced endoscopists familiar with these specialized procedures.
虽然文献中有许多报道描述了儿童内镜逆行胰胆管造影术(ERCP)的应用,但很少提及该技术在治疗患有胰腺或胆道疾病的儿科患者中的治疗应用。我们在此报告我们两年的经验,包括对25例患者进行了42次ERCP,用于各种胰胆管适应症。年龄范围从22个月到19岁。5例患者检查结果正常;其余患者被诊断患有各种胰腺和/或胆道异常。17例患者接受了治疗干预,包括括约肌切开术(n = 12)、扩张术(n = 6)或支架置入术(n = 9),其中许多操作是联合进行的。5例患者在ERCP后立即出现轻微腹痛或呕吐,但未遇到重大技术或医疗并发症。我们发现,治疗性ERCP可以在儿童中安全地进行,但前提是必须由熟悉这些专门操作的经验丰富的内镜医师进行。